Servier Symphogen News and Activities
Presence
Headquarters: Denmark
Laboratoire Servier has 6 subsidiaries including Biogaran, Day One Biopharmaceuticals and Servier Laboratory and Industrial.
They are in:
- Pharmaceuticals71%
- Biotechnology29%
Acquisition, funding and merger involving Laboratoire Servier.
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Laboratoire Servier has acquired Day One Biopharmaceuticals (posted on April 24 2026).
- Laboratoire Servier has announced the acquisition of Day One Biopharmaceuticals (posted on March 9 2026).
Executives
View the org chart displaying its 8 main executives
Most searched biographies at Servier Symphogen
- Christophe Thurieau, Chief Executive Officer and Director
- Benoit Cheron, Director
- Claude Bertrand, Chairman of the Board
Popular executive movements at Laboratoire Servier
- Eric Fohlen-Weill, Director of External Communication, has left the company (posted on October 17 2025).
Create your alert
to follow the executive moves at Servier Symphogen.
Biotechnology
Laboratoire Servier has 2,414 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- Nura Bio has just announced a $74 Million fundraising (posted on June 22 2026).
- Memento Medicines has just announced a $93 Million fundraising (posted on June 22 2026).
- Alvotech has just announced a $165 Million fundraising (posted on June 19 2026).
Popular contacts in Biotechnology
News
Press releases by Servier Symphogen
Social media about Servier Symphogen
- Servier Symphogen on Wikipedia, Google News & Yahoo Finance
- Servier Symphogen on LinkedIn, X (Twitter) & YouTube
